T1	PROC 46 74	Estudio aleatorizado abierto
T2	PROC 105 130	perfil lipídico en plasma
T3	CHEM 112 120	lipídico
#1	AnnotatorNotes T3	C0023779; Lipids; Organic Chemical
T4	ANAT 124 130	plasma
#2	AnnotatorNotes T4	C0032105; Plasma; Body Substance
T5	DISO 168 190	infección por el VIH-1
T6	CHEM 231 238	Atripla
#3	AnnotatorNotes T6	C1724016; Atripla; Organic Chemical · Pharmacologic Substance
T7	CHEM 280 287	Atripla
#4	AnnotatorNotes T7	C1724016; Atripla; Organic Chemical · Pharmacologic Substance
T8	DISO 329 348	Infección por VIH-1
#5	AnnotatorNotes T8	C2363741; HIV-1 infection; Disease or Syndrome
T9	DISO 434 454	infectados por VIH-1
#6	AnnotatorNotes T9	C2363741; HIV-1 infection; Disease or Syndrome
T10	CHEM 486 493	Atripla
#7	AnnotatorNotes T10	C1724016; Atripla; Organic Chemical · Pharmacologic Substance
T11	CHEM 571 574	ARN
#8	AnnotatorNotes T11	C0035668; RNA; Nucleic Acid, Nucleoside, or Nucleotide
T12	PROC 674 712	método anticonceptivo de doble barrera
T13	DISO 800 826	enfermedad aguda o crónica
T14	DISO 841 868	infección crónica por VIH-1
T15	PROC 897 919	análisis de lipidómica
T16	DISO 965 996	Abuso de alcohol u otras drogas
T17	PROC 737 761	consentimiento informado
#9	AnnotatorNotes T17	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T18	CHEM 1017 1025	fármacos
#10	AnnotatorNotes T18	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T19	CHEM 1070 1085	hipolipemiantes
#11	AnnotatorNotes T19	C0086440; Hypolipidemic Agents; Pharmacologic Substance
T20	CHEM 1087 1097	esteroides
#12	AnnotatorNotes T20	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T21	PROC 999 1002	IMC
#13	AnnotatorNotes T21	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T22	PROC 1137 1146	protocolo
#14	AnnotatorNotes T22	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T23	PROC 140 150	lipidómica
T24	PROC 1256 1265	protocolo
#15	AnnotatorNotes T24	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T25	DISO 1292 1299	alergia
#16	AnnotatorNotes T25	C1527304; Allergic Reaction; Pathologic Function
T26	CHEM 1316 1324	fármacos
#17	AnnotatorNotes T26	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T27	PROC 470 481	tratamiento
#18	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 571 578	ARN-VIH
T29	CHEM 242 250	Eviplera
T30	CHEM 1060 1068	lipídico
#19	AnnotatorNotes T30	C0023779; Lipids; Organic Chemical
T31	Date 13 17	2015
T32	LIVB 154 163	pacientes
#20	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	LIVB 377 386	Pacientes
#21	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	Age 395 421	igual o superior a 18 años
T35	LIVB 424 433	Pacientes
#22	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	LIVB 457 466	Pacientes
#23	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	Duration 495 531	al menos durante los últimos 6 meses
T38	LIVB 535 544	Pacientes
#24	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	LIVB 575 578	VIH
#25	AnnotatorNotes T39	C0019682; HIV; Virus
T40	Duration 592 628	al menos durante los últimos 6 meses
T41	LIVB 633 655	Mujeres en edad fértil
#26	AnnotatorNotes T41	C4324275; Woman of childbearing potential; Population Group
T42	Age 644 655	edad fértil
T44	Duration 819 826	crónica
#27	AnnotatorNotes T44	C0205191; chronic; Temporal Concept
T45	Duration 851 858	crónica
#28	AnnotatorNotes T45	C0205191; chronic; Temporal Concept
T47	LIVB 922 962	Mujer embaraza o en periodo de lactancia
#29	AnnotatorNotes T47	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T49	PHYS 1048 1068	metabolismo lipídico
#30	AnnotatorNotes T49	C0598783; Lipid Metabolism; Molecular Function
T50	LIVB 1102 1111	Pacientes
#31	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Neg_cue 1112 1124	incapaces de
T52	LIVB 1205 1217	investigador
#32	AnnotatorNotes T52	C0035173; Research Personnel; Professional or Occupational Group
T54	LIVB 185 190	VIH-1
#33	AnnotatorNotes T54	C0019704; HIV-1; Virus
T55	LIVB 343 348	VIH-1
#34	AnnotatorNotes T55	C0019704; HIV-1; Virus
T56	LIVB 449 454	VIH-1
#35	AnnotatorNotes T56	C0019704; HIV-1; Virus
T57	LIVB 863 868	VIH-1
#36	AnnotatorNotes T57	C0019704; HIV-1; Virus
T43	PHYS 928 936	embaraza
#37	AnnotatorNotes T43	C0032961; Pregnancy; Organism Function
T46	PHYS 953 962	lactancia
#38	AnnotatorNotes T46	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T48	PHYS 1125 1133	entender
#39	AnnotatorNotes T48	C0162340; Comprehension; Mental Process
T53	CHEM 990 996	drogas
#40	AnnotatorNotes T53	C0086190; Illicit Drugs; Hazardous or Poisonous Substance
A1	Population_data T41 Age
A2	Assertion T48 Negated
A3	Status T25 History_of
#41	AnnotatorNotes T1	C1709323; Open Label Study; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
#42	AnnotatorNotes T16	C0085762; Alcohol abuse; Mental or Behavioral Dysfunction + C0013146; Drug abuse; Mental or Behavioral Dysfunction
#43	AnnotatorNotes T5	C2363741; HIV-1 infection; Disease or Syndrome
#44	AnnotatorNotes T2	C1278073; Plasma lipid measurement; Laboratory Procedure 
#45	AnnotatorNotes T29	C3191262; Complera; Organic Chemical · Pharmacologic Substance 
#46	AnnotatorNotes T14	C2363741; HIV-1 infection; Disease or Syndrome + C0151317; Chronic Infection; Disease or Syndrome
T58	Spec_cue 874 879	pueda
T59	CONC 880 890	interferir
A4	Assertion T59 Speculated
#47	AnnotatorNotes T59	C0521102; Interferes with; Functional Concept
R1	Speculation Arg1:T58 Arg2:T59	
T60	Spec_cue 1030 1036	puedan
T61	CONC 1037 1044	afectar
A5	Assertion T61 Speculated
#48	AnnotatorNotes T61	C0521102; Interferes with; Functional Concept
R2	Speculation Arg1:T60 Arg2:T61	
T62	Spec_cue 1218 1223	pueda
T63	Observation 1224 1251	comprometer el cumplimiento
A6	Assertion T63 Speculated
#49	AnnotatorNotes T63	C3838706; Non-compliance of drug therapy; Finding (?)
R3	Speculation Arg1:T62 Arg2:T63	
T64	Food 974 981	alcohol
#50	AnnotatorNotes T64	C0001967; Alcoholic Beverages; Food
T65	Observation 195 215	supresión virológica
#51	AnnotatorNotes T65	C3888663; Sustained viral response; Finding (?)
T66	Observation 549 569	supresión virológica
#52	AnnotatorNotes T66	C3888663; Sustained viral response; Finding (?)
R4	Experiences Arg1:T38 Arg2:T66	
R5	Experiences Arg1:T38 Arg2:T28	
T67	Result_or_Value 579 590	< 50 cop/ml
R6	Has_Result_or_Value Arg1:T28 Arg2:T67	
#53	AnnotatorNotes T28	C1294179; HIV 1 RNA assay (?); Laboratory Procedure
R7	Has_Duration_or_Interval Arg1:T66 Arg2:T40	
R8	Overlap Arg1:T28 Arg2:T40	
R9	Location_of Arg1:T4 Arg2:T2	
R10	Experiences Arg1:T32 Arg2:T2	
R11	Experiences Arg1:T32 Arg2:T23	
R12	Experiences Arg1:T32 Arg2:T5	
R13	Causes Arg1:T54 Arg2:T5	
R14	Before Arg1:T5 Arg2:T65	
R15	Before Arg1:T6 Arg2:T29	
R16	Experiences Arg1:T32 Arg2:T65	
R17	Experiences Arg1:T32 Arg2:T6	
R18	Experiences Arg1:T32 Arg2:T29	
R19	Experiences Arg1:T32 Arg2:T7	
R20	Causes Arg1:T55 Arg2:T8	
R21	Has_Age Arg1:T33 Arg2:T34	
R22	Causes Arg1:T56 Arg2:T9	
R23	Experiences Arg1:T35 Arg2:T9	
R24	Experiences Arg1:T36 Arg2:T27	
R25	Used_for Arg1:T10 Arg2:T27	
R26	Has_Duration_or_Interval Arg1:T10 Arg2:T37	
R27	Has_Age Arg1:T41 Arg2:T42	
R28	Experiences Arg1:T41 Arg2:T12	
R29	Has_Duration_or_Interval Arg1:T13 Arg2:T44	
#55	AnnotatorNotes T13	C0001314; Acute Disease; Disease or Syndrome | C0008679; Chronic disease; Disease or Syndrome
R30	Overlap Arg1:T13 Arg2:T14	
R31	Has_Duration_or_Interval Arg1:T14 Arg2:T45	
R32	Causes Arg1:T57 Arg2:T14	
R37	Experiences Arg1:T47 Arg2:T43	
R38	Experiences Arg1:T47 Arg2:T46	
R39	Causes Arg1:T64 Arg2:T16	
R40	Causes Arg1:T53 Arg2:T16	
T69	Result_or_Value 1003 1007	> 25
R41	Has_Result_or_Value Arg1:T21 Arg2:T69	
R44	Used_for Arg1:T30 Arg2:T49	
R47	Overlap Arg1:T48 Arg2:T22	
R48	Negation Arg1:T51 Arg2:T48	
R49	Experiences Arg1:T50 Arg2:T48	
R50	Experiences Arg1:T50 Arg2:T63	
R51	Overlap Arg1:T48 Arg2:T24	
R52	Causes Arg1:T26 Arg2:T25	
A7	Experiencer T32 Patient
A8	Experiencer T33 Patient
A9	Experiencer T35 Patient
A10	Experiencer T36 Patient
A11	Experiencer T38 Patient
A12	Experiencer T41 Patient
A13	Experiencer T47 Patient
A14	Experiencer T50 Patient
A15	Experiencer T52 Other
